Evidence map›Paper›PMID 38478100›Full record

ArticleWorld journal of urology2024

Robot-assisted single-port retroperitoneal partial nephrectomy with a novel purpose-built single-port robotic system with deformable surgical instruments.

Chao Zhang, Zheng Wang, Taile Jing, Yong Wei, Fei Guo, Zongqin Zhang, Chengwu Xiao, Yang Wang, Hong Xu, Xiaofeng Wu and 7 more

Open access · hybridAbstract read
In one paragraph

Article in World journal of urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. [Current Applications and Future Prospects of Laparoendoscopic Single-Site Surgery in Urology].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Chao Zhang *Department Urology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
Zheng Wang *Department Urology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
Taile Jing *Department Urology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China.
Yong Wei *Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210011, China.
Fei GuoDepartment Urology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
Zongqin ZhangDepartment Urology, The Second Affiliated Hospital of Naval Medical University, Shanghai, 200003, China.
Chengwu XiaoDepartment Urology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
Yang WangDepartment Urology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
Hong XuDepartment Urology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
Xiaofeng WuDepartment Urology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
Shouyan TangDepartment Urology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
Bo YangDepartment Urology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
Shuo WangDepartment Urology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China.
Bin XuDepartment Urology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200125, China. chxb2004@shsmu.edu.cn.
Qingyi ZhuDepartment of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210011, China. zhuqy1971@126.com.
Dan XiaDepartment Urology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China. xiadan@zju.edu.cn.
Linhui WangDepartment Urology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China. wanglinhuicz@163.com.
First Affiliated Hospital Zhejiang University · CNSecond Affiliated Hospital of Nanjing Medical University · CNSecond Military Medical University · CNShanghai First People's Hospital · CNShanghai Ninth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the safety and feasibility of using a novel purpose-built single-port robotic system (the SHURUI Robotic Surgical System) with deformable surgical instruments to perform retroperitoneal single-port partial nephrectomy. MATERIALS AND

methodsA prospective study was conducted to recruit patients with a single renal tumor no more than 4 cm. Robot-assisted single-port partial nephrectomy was performed by using the novel purpose-built single-port robotic system with deformable surgical instruments. Patients' demographics, tumor characteristics, and perioperative parameters were recorded and analyzed.

resultsSixteen patients were recruited to the study. The median tumor size was 2.0 cm (IQR: 1.2-2.4 cm). The median R.E.N.A.L score was 6 (IQR: 4-4.5). In 3 cases, pure single-port surgery was carried out, and all the assistance was through the robotic port. Median docking time was 15.5 min (IQR: 14.25-22.25 min). Median operating time was 148.5 min (IQR: 178-238.5 min). Median console time was 107 min (IQR: 92.75-149.75 min). Median warm ischemic time was 26.5 min (IQR: 24.5-30 min). Median blood loss was 17.5 ml (IQR: 10-50 ml).

conclusionsRetroperitoneal partial nephrectomy can be safely performed with this novel purpose-built single-port robotic system (SHURUI) with deformable surgical instruments. Further studies are needed to fully evaluate the role of this new platform.

Indexed as

Kidney NeoplasmsRoboticsRobotic Surgical ProceduresHumansNephrectomyProspective StudiesRetrospective StudiesTreatment OutcomePartial nephrectomyRetroperitoneal surgeryRobotic surgerySingle-port surgery

Identifiers

PMID38478100
PMCPMC10937792
OpenAlexW4392747772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.